Shield AI Buys Echodyne for $5.3B at $28.8B Valuation

TL;DR: Shield AI agreed on November 5, 2026 to acquire radar maker Echodyne in a deal valued at $5.3 billion. It is raising $2.5 billion to pay for it, including a $1 billion Series H at a $28.8 billion valuation. Closing is expected in early 2027, and the financing depends on it.

The announcement came from Shield AI, and it is worth reading as two transactions bolted together: a purchase and a financing. They carry different risks for anyone watching defense tech from the outside.

What exactly did Shield AI announce?

Shield signed a definitive agreement to buy Echodyne Corp. for $5.3 billion. Of that, Shield says $4.8 billion will be paid and issued at closing, and up to $500 million more depends on Echodyne meeting agreed performance targets.

To fund it, Shield is raising $2.5 billion from three different kinds of capital, laid out in the same release:

Piece	Amount	Who provides it
Series H equity	$1 billion, at a $28.8 billion post-money valuation	Co-led by Disruptive and Innovation X Capital
Structured equity	$1 billion	Funds managed by Blackstone
Debt	$500 million	Led by JPMorgan Chase Bank, N.A.

The split matters. Only the first line is ordinary venture equity. The Blackstone money is structured equity, which usually comes with terms that protect the investor more than common stock does, and the release doesn't publish those terms, so the real cost of that $1 billion is unknown. The Series H co-leads come from the PR Newswire version of the release.

What is Echodyne, and why would Shield pay this much?

Echodyne makes radar, the sensor that spots a drone before anything can be done about it. According to Shield's release, its radars are built into hundreds of counter-drone and security systems used by defense, government and commercial customers in more than 40 countries.

The same release lists two things that explain the price. In September, Echodyne received a contract with a $250 million ceiling from Joint Interagency Task Force 401 for counter-drone radar. And its new Kirkland, Washington factory, a $40 million investment, can produce about 30,000 radars a year. A ceiling is the most a contract can pay. It is not revenue.

For Shield, the fit is described by its lawyers at Sullivan & Cromwell. The deal builds out the Mission Systems business with software-defined radars that enable counter-unmanned aircraft systems, which detect, track and defeat drones.

How much did Shield's valuation jump?

It more than doubled. Bloomberg reported that $28.8 billion is more than double the valuation Shield struck in March, when it raised $2 billion at a $12.7 billion value.

One caution on the March round. Our earlier coverage of it framed the round size differently from Bloomberg's $2 billion, while the $12.7 billion valuation is the same in both. For the round structure, check Shield's own March announcement before relying on either. Our analysis of that round covers what it meant at the time.

Shield has raised $5.4 billion in equity to date, according to Bloomberg via Yahoo Finance, from backers including Andreessen Horowitz and Point72 Ventures.

Can an individual accredited investor take part?

Not from anything we've read. The release and the coverage name institutions and funds only, and none of them describes a route for individuals into this Series H, the structured equity or the debt. For an accredited investor, this is a theme to understand, not a deal on offer.

What the deal does show is how much late-stage capital is concentrating in defense technology. Related coverage on Impulse Space's defense-tech round shows the same pattern at a smaller scale. When a valuation doubles in eight months, the later buyer, whether a fund or a platform selling access, is paying for a great deal of expected growth.

What happens next?

Closing is not done. Battle Policy reports that Shield expects to close in early 2027, subject to regulatory approvals and customary closing conditions. The financing is tied to it: Bloomberg's report says the $2.5 billion won't proceed if the deal falls through.

There is a second funding need outside this deal. Shield's CEO said the company plans to raise more than $1 billion early next year to fund production of its X-BAT jet, per the same Bloomberg report. Battle Policy notes the Series H is earmarked principally for Echodyne and does not address that production financing.

Watch three things: regulatory approval, whether Echodyne hits the targets behind the $500 million contingent payment, and the terms of the next raise.

Common mistakes when reading a deal like this

The first is treating the headline number as cash. The $5.3 billion includes up to $500 million that is paid only if Echodyne hits its targets, and part of the $4.8 billion is issued as stock, not wired. The second is reading the $28.8 billion as a price anyone can pay. It is a post-money valuation set by the lead investors in one round.

The third is mixing up a contract ceiling with revenue. A $250 million ceiling tells you what the customer may order at most, and says nothing about what it will. The fourth is repeating a figure from a site that copied it. Use the company release and the outlet that reported it first.

FAQ

How much is Shield AI paying for Echodyne?

The deal is valued at $5.3 billion. Shield says $4.8 billion is paid and issued at closing, and up to $500 million more depends on Echodyne meeting agreed performance targets.

What is Shield AI's valuation after the Series H?

Shield's release puts the Series H at a $28.8 billion post-money valuation. Bloomberg reports that is more than double the $12.7 billion valuation from March.

Who is funding the deal?

The $2.5 billion combines a $1 billion Series H, a $1 billion structured equity investment from funds managed by Blackstone, and $500 million in debt led by JPMorgan Chase Bank, N.A.

When will the acquisition close?

Shield expects to close in early 2027, according to Battle Policy, subject to regulatory approvals and customary closing conditions. The financing proceeds only if the acquisition closes.

What to do today

Open Shield's release and write down the five figures that matter: the $5.3 billion price, the $4.8 billion at closing, the $500 million contingent amount, and the equity and debt pieces of the $2.5 billion. Next to each, note whether it is cash, stock or a conditional promise. If you can't fill in a column, that is your next due diligence question. For more deal news read this way, subscribe to the free AIN briefing.

Educational content only. Not investment, tax, or legal advice. Not an offer or solicitation to buy or sell securities. Past performance does not guarantee future results. Private-market investments are illiquid and involve risk of loss, including total loss of capital. Consult qualified advisers. Angel Investors Network is not a broker-dealer or investment adviser.